Impact of Out-of-Pocket Cost on Herpes Zoster Vaccine Uptake: An Observational Study in a Medicare Managed Care Population

Herpes zoster (HZ) vaccination is approved for adults aged 50+ for the prevention of HZ, but it is underutilized. The objective of this study was to evaluate the association between out-of-pocket cost and HZ vaccine utilization. Adults aged 65 or older enrolled for at least 12 months in Medicare Adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Zhuliang, Li, Yong, Stemkowski, Stephen, Johnson, Kelly D., Acosta, Camilo J., Zhang, Dongmu, Fendrick, A. Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313857/
https://www.ncbi.nlm.nih.gov/pubmed/30469449
http://dx.doi.org/10.3390/vaccines6040078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313857/
https://www.ncbi.nlm.nih.gov/pubmed/30469449
http://dx.doi.org/10.3390/vaccines6040078

Ejemplares similares